Extranodal NK-T-cell lymphoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(24 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{RG}} {{AS}}
{{CMG}}; {{AE}} {{RG}} {{AS}}
==Overview==
==Overview==
<br />
NK cell lymphoma shows a poor [[prognosis]] because of rapid local progression and distant [[metastasis]].The [[median]] age of onset is approximately 50 years and it is common in elderly. [[extranodal NK/T-cell lymphoma]] is a rare disease in children and often it is associated with mosquito-bite [[hypersensitivity]] or other [[EBV]]-associated disease[[Natural Killer cell|.Natural Killer (NK) cell]] lymphoma is a rare disease. [[Extranodal NK-T-cell lymphoma|extranodal NK/T cell lymphoma]], nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.NK T cell lymphoma, nasal type (NNKTL) consist 3000-10000 out of 100000 cases of [[non-Hodgkin lymphoma]] in Asia and South America and less than 1000 in 10000 patient in western countries<br />


== Epidemiology and Demographics ==
== Epidemiology and Demographics ==


=== Incidence ===
=== Mortality rate ===
Natural Killer (NK) cell lympoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell lukemia (ANKCL) have higher incidence Asia , Central and South America.
 
* NK cell lymphoma shows a poor [[prognosis]] because of rapid local progression and distant [[Metastasis - brain|metastasis]].<ref name="JaffeNicolae2013">{{cite journal|last1=Jaffe|first1=Elaine S|last2=Nicolae|first2=Alina|last3=Pittaluga|first3=Stefania|title=Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls|journal=Modern Pathology|volume=26|issue=S1|year=2013|pages=S71–S87|issn=0893-3952|doi=10.1038/modpathol.2012.181}}</ref>
 
=== Age ===
 
* The [[median]] age of onset is approximately 50 years and it is common in the elderly.
*[[Extranodal NK-T-cell lymphoma|Extranodal NK/T-cell lymphoma]] is a rare disease in children and often it is associated with mosquito-bite [[hypersensitivity]] or other [[Epstein Barr virus|EBV]]-associated disease.<ref name="HarabuchiTakahara2019">{{cite journal|last1=Harabuchi|first1=Yasuaki|last2=Takahara|first2=Miki|last3=Kishibe|first3=Kan|last4=Nagato|first4=Toshihiro|last5=Kumai|first5=Takumi|title=Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress|journal=Frontiers in Pediatrics|volume=7|year=2019|issn=2296-2360|doi=10.3389/fped.2019.00141}}</ref>
 
 
=== Race ===
 
*[[Natural killer cell|Natural Killer (NK) cell]] lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
* Nk cell lymphoma is usually associated with [[Epstein Barr virus|Epstein-Barr virus]] infection.<ref name="Lima2013">{{cite journal|last1=Lima|first1=Margarida|title=Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis|journal=Orphanet Journal of Rare Diseases|volume=8|issue=1|year=2013|pages=95|issn=1750-1172|doi=10.1186/1750-1172-8-95}}</ref>
 
 
=== Gender ===
 
*[[Extranodal NK-T-cell lymphoma|Extranodal NK/T-cell lymphoma]] shows male preponderance.<ref name="WangGong2017">{{cite journal|last1=Wang|first1=Xiaotian|last2=Gong|first2=Zimu|last3=Li|first3=Shawn Xiang|last4=Yan|first4=Wei|last5=Song|first5=Yongsheng|title=Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature|journal=BMC Urology|volume=17|issue=1|year=2017|issn=1471-2490|doi=10.1186/s12894-017-0273-8}}</ref>
 
 
=== Region ===
 
*[[Extranodal NK-T-cell lymphoma|Extranodal NK T cell lymphoma]], nasal type (NNKTL) consist 3000-10000 out of 100000 cases of [[non-Hodgkin lymphoma]] in Asia and South America and less than 1000 in 10000 patient in western countries.
*It is estimated the incidence of NNKTL is higher in Asia by 10-folds.<ref name="HaverkosPan2016">{{cite journal|last1=Haverkos|first1=Bradley M.|last2=Pan|first2=Zenggang|last3=Gru|first3=Alejandro A.|last4=Freud|first4=Aharon G.|last5=Rabinovitch|first5=Rachel|last6=Xu-Welliver|first6=Meng|last7=Otto|first7=Brad|last8=Barrionuevo|first8=Carlos|last9=Baiocchi|first9=Robert A.|last10=Rochford|first10=Rosemary|last11=Porcu|first11=Pierluigi|title=Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases|journal=Current Hematologic Malignancy Reports|volume=11|issue=6|year=2016|pages=514–527|issn=1558-8211|doi=10.1007/s11899-016-0355-9}}</ref>
 
 
== References ==
<references />

Latest revision as of 13:27, 28 October 2019

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics

CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics

Extranodal NK-T-cell lymphoma epidemiology and demographics in the news

Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.The median age of onset is approximately 50 years and it is common in elderly. extranodal NK/T-cell lymphoma is a rare disease in children and often it is associated with mosquito-bite hypersensitivity or other EBV-associated disease.Natural Killer (NK) cell lymphoma is a rare disease. extranodal NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.NK T cell lymphoma, nasal type (NNKTL) consist 3000-10000 out of 100000 cases of non-Hodgkin lymphoma in Asia and South America and less than 1000 in 10000 patient in western countries

Epidemiology and Demographics

Mortality rate

Age


Race

  • Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
  • Nk cell lymphoma is usually associated with Epstein-Barr virus infection.[3]


Gender


Region

  • Extranodal NK T cell lymphoma, nasal type (NNKTL) consist 3000-10000 out of 100000 cases of non-Hodgkin lymphoma in Asia and South America and less than 1000 in 10000 patient in western countries.
  • It is estimated the incidence of NNKTL is higher in Asia by 10-folds.[5]


References

  1. Jaffe, Elaine S; Nicolae, Alina; Pittaluga, Stefania (2013). "Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls". Modern Pathology. 26 (S1): S71–S87. doi:10.1038/modpathol.2012.181. ISSN 0893-3952.
  2. Harabuchi, Yasuaki; Takahara, Miki; Kishibe, Kan; Nagato, Toshihiro; Kumai, Takumi (2019). "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress". Frontiers in Pediatrics. 7. doi:10.3389/fped.2019.00141. ISSN 2296-2360.
  3. Lima, Margarida (2013). "Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis". Orphanet Journal of Rare Diseases. 8 (1): 95. doi:10.1186/1750-1172-8-95. ISSN 1750-1172.
  4. Wang, Xiaotian; Gong, Zimu; Li, Shawn Xiang; Yan, Wei; Song, Yongsheng (2017). "Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature". BMC Urology. 17 (1). doi:10.1186/s12894-017-0273-8. ISSN 1471-2490.
  5. Haverkos, Bradley M.; Pan, Zenggang; Gru, Alejandro A.; Freud, Aharon G.; Rabinovitch, Rachel; Xu-Welliver, Meng; Otto, Brad; Barrionuevo, Carlos; Baiocchi, Robert A.; Rochford, Rosemary; Porcu, Pierluigi (2016). "Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases". Current Hematologic Malignancy Reports. 11 (6): 514–527. doi:10.1007/s11899-016-0355-9. ISSN 1558-8211.